Seer, Inc. (NASDAQ:SEER) Stake Boosted by JPMorgan Chase & Co.

JPMorgan Chase & Co. raised its position in shares of Seer, Inc. (NASDAQ:SEERFree Report) by 67.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 175,354 shares of the company’s stock after buying an additional 70,671 shares during the quarter. JPMorgan Chase & Co. owned 0.30% of Seer worth $345,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in SEER. American Century Companies Inc. grew its position in Seer by 42.1% during the 2nd quarter. American Century Companies Inc. now owns 61,752 shares of the company’s stock worth $104,000 after purchasing an additional 18,302 shares in the last quarter. Cubist Systematic Strategies LLC acquired a new position in Seer in the 2nd quarter valued at approximately $133,000. AQR Capital Management LLC purchased a new stake in Seer in the 2nd quarter worth approximately $30,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Seer during the 2nd quarter valued at $148,000. Finally, Point72 DIFC Ltd purchased a new position in shares of Seer during the 2nd quarter valued at $35,000. 75.20% of the stock is owned by hedge funds and other institutional investors.

Seer Trading Down 2.1 %

NASDAQ SEER opened at $2.33 on Thursday. Seer, Inc. has a 1-year low of $1.51 and a 1-year high of $2.63. The firm’s fifty day simple moving average is $2.38 and its 200-day simple moving average is $2.05. The company has a market capitalization of $137.40 million, a PE ratio of -1.79 and a beta of 1.57.

Seer Company Profile

(Free Report)

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.

Further Reading

Institutional Ownership by Quarter for Seer (NASDAQ:SEER)

Receive News & Ratings for Seer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seer and related companies with MarketBeat.com's FREE daily email newsletter.